These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 28078757)

  • 41. Induction of laminitis by prolonged hyperinsulinaemia in clinically normal ponies.
    Asplin KE; Sillence MN; Pollitt CC; McGowan CM
    Vet J; 2007 Nov; 174(3):530-5. PubMed ID: 17719811
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increased expression of MAIL, a cytokine-associated nuclear protein, in the prodromal stage of black walnut-induced laminitis.
    Waguespack RW; Kemppainen RJ; Cochran A; Lin HC; Belknap JK
    Equine Vet J; 2004 Apr; 36(3):285-91. PubMed ID: 15147139
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Current concepts on the pathophysiology of pasture-associated laminitis.
    Geor RJ
    Vet Clin North Am Equine Pract; 2010 Aug; 26(2):265-76. PubMed ID: 20699174
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Decreased expression of p63, a regulator of epidermal stem cells, in the chronic laminitic equine hoof.
    Carter RA; Engiles JB; Megee SO; Senoo M; Galantino-Homer HL
    Equine Vet J; 2011 Sep; 43(5):543-51. PubMed ID: 21496086
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The sodium-glucose co-transporter 2 inhibitor velagliflozin reduces hyperinsulinemia and prevents laminitis in insulin-dysregulated ponies.
    Meier A; Reiche D; de Laat M; Pollitt C; Walsh D; Sillence M
    PLoS One; 2018; 13(9):e0203655. PubMed ID: 30212530
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ultrastructural examination of basement membrane pathology in horses with insulin-induced laminitis.
    de Laat MA; Pollitt CC
    Domest Anim Endocrinol; 2019 Oct; 69():30-34. PubMed ID: 31280023
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Endocrinopathic Laminitis.
    Grenager NS
    Vet Clin North Am Equine Pract; 2021 Dec; 37(3):619-638. PubMed ID: 34674908
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Incidence and risk factors for recurrence of endocrinopathic laminitis in horses.
    de Laat MA; Reiche DB; Sillence MN; McGree JM
    J Vet Intern Med; 2019 May; 33(3):1473-1482. PubMed ID: 30972832
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association between hyperinsulinaemia and laminitis severity at the time of pituitary pars intermedia dysfunction diagnosis.
    Tadros EM; Fowlie JG; Refsal KR; Marteniuk J; Schott HC
    Equine Vet J; 2019 Jan; 51(1):52-56. PubMed ID: 29761574
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of Continuous Digital Hypothermia on Lamellar Inflammatory Signaling When Applied at a Clinically-Relevant Timepoint in the Oligofructose Laminitis Model.
    Dern K; van Eps A; Wittum T; Watts M; Pollitt C; Belknap J
    J Vet Intern Med; 2018 Jan; 32(1):450-458. PubMed ID: 29282770
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association of the glycoxidative stress marker pentosidine with equine laminitis.
    Valle E; Storace D; Sanguineti R; Carter R; Odetti P; Geor R; Bergero D
    Vet J; 2013 Jun; 196(3):445-50. PubMed ID: 23206662
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of hypothermia on influx of leukocytes in the digital lamellae of horses with oligofructose-induced laminitis.
    Godman JD; Burns TA; Kelly CS; Watts MR; Leise BS; Schroeder EL; van Eps AW; Belknap JK
    Vet Immunol Immunopathol; 2016 Oct; 178():22-8. PubMed ID: 27496739
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Laminitis and the equine metabolic syndrome.
    Johnson PJ; Wiedmeyer CE; LaCarrubba A; Ganjam VK; Messer NT
    Vet Clin North Am Equine Pract; 2010 Aug; 26(2):239-55. PubMed ID: 20699172
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Digital lamellar inflammatory signaling in an experimental model of equine preferential weight bearing.
    Burns TA; Watts MR; Belknap JK; van Eps AW
    J Vet Intern Med; 2023 Mar; 37(2):681-688. PubMed ID: 36840365
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Equine laminitis: its development coincides with increased sublamellar blood flow.
    Pollitt CC; Davies CT
    Equine Vet J Suppl; 1998 Sep; (26):125-32. PubMed ID: 9932103
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Are There Shared Mechanisms in the Pathophysiology of Different Clinical Forms of Laminitis and What Are the Implications for Prevention and Treatment?
    van Eps AW; Burns TA
    Vet Clin North Am Equine Pract; 2019 Aug; 35(2):379-398. PubMed ID: 31126692
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of insulin on IGF-1 receptors in equine lamellar tissue in vitro.
    Rahnama S; Spence R; Vathsangam N; Baskerville CL; Bailey SR; de Laat MA; Anderson ST; Pollitt CC; Sillence MN
    Domest Anim Endocrinol; 2021 Jan; 74():106530. PubMed ID: 32818904
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inflammatory and redox status of ponies with a history of pasture-associated laminitis.
    Treiber K; Carter R; Gay L; Williams C; Geor R
    Vet Immunol Immunopathol; 2009 Jun; 129(3-4):216-20. PubMed ID: 19108899
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Plasma concentrations of inflammatory markers in previously laminitic ponies.
    Wray H; Elliott J; Bailey SR; Harris PA; Menzies-Gow NJ
    Equine Vet J; 2013 Sep; 45(5):546-51. PubMed ID: 23418944
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The timeline of metalloprotease events during oligofructose induced equine laminitis development.
    Visser MB; Pollitt CC
    Equine Vet J; 2012 Jan; 44(1):88-93. PubMed ID: 21696433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.